A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG

Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism

(2016) A. Jafarzadeh et al.   Cancer Biomarkers

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

(2016) Claudia Cantoni et al.   Journal of Immunology Research

Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma

(2015) M Sadeghi et al.   BRITISH JOURNAL OF CANCER

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

(2015) Michael S. Isakoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis

(2015) M. N. D. Svensson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

(2015) Françoise Redini et al.   Frontiers in Oncology

Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma

(2015) Feng Lian et al.   PLoS One

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†

(2014) J. S. Whelan et al.   ANNALS OF ONCOLOGY

Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis

(2014) Jian Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Impact of RANK signalling on survival and chemotherapy response in osteosarcoma

(2014) Zsuzsanna Bago-Horvath et al.   PATHOLOGY

Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models

(2013) Huilian Bu et al.   BREAST CANCER RESEARCH AND TREATMENT

Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling

(2013) L.-Y. Fang et al.   CANCER RESEARCH

Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment

(2013) Reinhard Buettner et al.   JOURNAL OF CLINICAL ONCOLOGY

The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma

(2012) Zhenqian Wu et al.   BIOMEDICINE & PHARMACOTHERAPY

A systems biology approach reveals common metastatic pathways in osteosarcoma

(2012) Ricardo J Flores et al.   BMC Systems Biology

STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma

(2012) Bing Tu et al.   CANCER LETTERS

EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis

(2011) Peng Chen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency

(2011) Venetia Bigley et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Building strong bones: molecular regulation of the osteoblast lineage

(2011) Fanxin Long   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo

(2010) Terry OʼReilly et al.   ANTI-CANCER DRUGS

Elevated expression of CXC chemokines in pediatric osteosarcoma patients

(2010) Yiting Li et al.   CANCER

Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

(2010) J. Smida et al.   CLINICAL CANCER RESEARCH

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs

(2009) Emmanuelle Pradelli et al.   INTERNATIONAL JOURNAL OF CANCER

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

(2009) Guillaume Darrasse-Jèze et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A complex pattern of chemokine receptor expression is seen in osteosarcoma

(2008) Irene von Luettichau et al.   BMC CANCER

Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats

(2008) C. Chauvin et al.   CANCER RESEARCH

Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-  and CXCR3 Ligands

(2008) M. Wendel et al.   CANCER RESEARCH